Meghan Bishop, MD
Orthopaedic Surgery · Marlton, NJNPI 1629334941
Payments from drug & device makers
Across 81 payments — averaging $219.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gotham Surgical Solutions & Devices, Inc.$7K
- Arthrex$5K
- Averitas Pharma Inc.$3K
- Stryker$1K
- Eclipse Technology Solutions Inc.$516
- Smith+Nephew$348
- plus $762 from 8 others
What the payments were for
- Speaking & faculty fees$3,00017%
- Travel & lodging$2,22913%
- Food & beverage$3,18618%
- Education$9,34053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gotham Surgical Solutions & Devices, Inc. | 10 | $6,924 |
| Arthrex | 28 | $5,014 |
| Averitas Pharma Inc. | 3 | $3,045 |
| Stryker(2 entities) | 14 | $1,146 |
| Eclipse Technology Solutions Inc. | 8 | $516 |
| Smith+Nephew | 4 | $348 |
| Johnson & Johnson | 5 | $267 |
| Acumed LLC | 1 | $149 |
| Vericel Corporation | 1 | $106 |
| Arthrosurface Incorporated | 1 | $102 |
| Ferring Pharmaceuticals Inc. | 3 | $60 |
| Bioventus LLC | 1 | $39 |
| Catalyst Orthoscience | 1 | $28 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REUNION$357
- NOVOSTITCH$281
- BLUEPRINT PSI SYSTEM$269
- AUGMENT INJECTABLE$165
- Clavicle Plating System$149
- ORTHOVISC$113
- MONOVISC$113
- ADAPT$111
- MACI$106
- HemiCAP Shoulder$102
How this compares
$17,755 in reported general payments places this provider in the 75th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 33 | $214 |
| Naproxen | 45 | $142 |
| Famotidine | 26 | $83 |
| Tramadol Hcl | 38 | $62 |
| Ondansetron Hcl | 29 | $58 |
| Oxycodone Hcl | 28 | $58 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Marlton
- David NazarianMarlton$1.3M
- Joseph DanielMarlton$101K
- Michael KellyHackensack$9.7M
- Mark HartzbandParamus$9.4M
- Luke AustinSewell$4.3M
- Randal BetzLawrenceville$3M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Gregg KleinParamus$1.6M
- Harlan LevineMontvale$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.